Overview
Agnathia-holoprosencephaly-situs inversus syndrome, also known as agnathia-otocephaly complex or otocephaly, is an extremely rare and typically lethal congenital malformation syndrome. It is characterized by three cardinal features: agnathia (absence or severe underdevelopment of the mandible/lower jaw), holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres), and situs inversus (a mirror-image reversal of the normal positioning of internal organs). The condition profoundly affects craniofacial development, the central nervous system, and visceral organ arrangement. Key clinical features include absence or severe hypoplasia of the mandible, microstomia (abnormally small mouth) or astomia (absence of the mouth), synotia (fusion or medial displacement of the ears, sometimes beneath the chin), and varying degrees of holoprosencephaly ranging from alobar to semilobar forms. Additional findings may include cyclopia or other ocular anomalies, absence of the tongue (aglossia), and abnormalities of the pharynx and upper airway. Situs inversus totalis or other laterality defects are variably present. The condition is almost invariably fatal in the perinatal period due to severe airway compromise and brain malformations. The etiology remains incompletely understood. Most reported cases are sporadic, though some evidence suggests possible autosomal recessive inheritance in rare familial cases. Mutations in the PRRX1 gene have been implicated in some cases of otocephaly. Diagnosis is typically made prenatally via ultrasound or at birth based on the characteristic physical findings. There is no curative treatment; management is supportive and palliative. Genetic counseling is recommended for affected families.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Agnathia-holoprosencephaly-situs inversus syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Agnathia-holoprosencephaly-situs inversus syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Agnathia-holoprosencephaly-situs inversus syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Agnathia-holoprosencephaly-situs inversus syndrome.
Community
No community posts yet. Be the first to share your experience with Agnathia-holoprosencephaly-situs inversus syndrome.
Start the conversation →Latest news about Agnathia-holoprosencephaly-situs inversus syndrome
No recent news articles for Agnathia-holoprosencephaly-situs inversus syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Agnathia-holoprosencephaly-situs inversus syndrome
What is Agnathia-holoprosencephaly-situs inversus syndrome?
Agnathia-holoprosencephaly-situs inversus syndrome, also known as agnathia-otocephaly complex or otocephaly, is an extremely rare and typically lethal congenital malformation syndrome. It is characterized by three cardinal features: agnathia (absence or severe underdevelopment of the mandible/lower jaw), holoprosencephaly (a failure of the forebrain to properly divide into two hemispheres), and situs inversus (a mirror-image reversal of the normal positioning of internal organs). The condition profoundly affects craniofacial development, the central nervous system, and visceral organ arrangeme
At what age does Agnathia-holoprosencephaly-situs inversus syndrome typically begin?
Typical onset of Agnathia-holoprosencephaly-situs inversus syndrome is neonatal. Age of onset can vary across affected individuals.